Sciomics GmbH was founded in the spring of 2013 as a spin-off company of the German Cancer Research Center (DKFZ) by Dr. Christoph Schröder and Dr. Jörg Hoheisel. Since 2003, Sciomics’ team has gained experience with production and application of antibody microarrays as a tool for analysing complex protein samples. With this background, Sciomics is able to offer complete analysis of its costumers’ samples with standardised as well as customised arrays.